Stocktoria
ADIAL PHARMACEUTICALS, INC. ADIL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-07-27
ADIAL PHARMACEUTICALS, INC. statistics & valuation
Market cap$5.6M
P / B1.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -119.5% | -261.6% | -108.2% | -222.1% | -259.8% |
| Return on equity | -151.2% | -324.4% | -125.5% | -388.6% | -553.7% |
| Current ratio | 4.42 | 4.16 | 4.90 | 2.67 | 2.37 |
Source: SEC EDGAR filings · CIK 0001513525 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.